Copyright
©The Author(s) 2005.
World J Gastroenterol. Oct 21, 2005; 11(39): 6193-6196
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6193
Published online Oct 21, 2005. doi: 10.3748/wjg.v11.i39.6193
Group I(n=6) | Group II(n=7) | P | |
Age, year (range) | 57.6 (39-79) | 65.6 (38 – 81) | 0.34 |
Gender (male/female) | 6/0 | 5/2 | - |
Pretreatment AFP (ng/ml) | 707 ±1536 | 3024 ±5307 | 0.32 |
Tumor size (cm) | 5.92 ± 3.98 | 5.00 ± 2.20 | 0.61 |
Disease status at entry | - | ||
For the first time TAE (n) | 3 | 2 | |
For recurrence (n) | 3 | 5 | |
Lipiodol retention (%) | 79.31 ± 28.79 | 18.43 ± 10.61 | 0.02a |
- Citation: Su YW, Huang YW, Chen SH, Tzen CY. Quantitative analysis of plasma HBV DNA for early evaluation of the response to transcatheter arterial embolization for HBV-related hepatocellular carcinoma. World J Gastroenterol 2005; 11(39): 6193-6196
- URL: https://www.wjgnet.com/1007-9327/full/v11/i39/6193.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i39.6193